hydralazine has been researched along with Hemorrhage in 15 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Hemorrhage: Bleeding or escape of blood from a vessel.
Excerpt | Relevance | Reference |
---|---|---|
"Hydralazine is a common vasodilator which has been used for the treatment of hypertension and heart failure." | 7.96 | Hydralazine-induced antineutrophil cytoplasmic antibody-associated vasculitis with pulmonary-renal syndrome: a case report. ( Al-Abdouh, A; Bekele, A; Garcia, P; Seid, H; Siyal, AM, 2020) |
"We report a rare case of Hydralazine-induced ANCA associated glomerulonephritis with alveolar hemorrhage in the setting of acute Clostridium Difficile Infection." | 7.83 | Hydralazine-Induced ANCA Vasculitis in the Setting of Acute Clostridium Difficile Infection. ( Cucu, DF; El Meligy, A; Rasla, S, 2016) |
"Hydralazine-induced lupus was first described in 1953." | 5.48 | Hydralazine-associated antineutrophil cytoplasmic antibody vasculitis with pulmonary-renal syndrome. ( Aeddula, NR; Ansari, A; Juran, PJ; Pathireddy, S, 2018) |
"Hydralazine, an arterial vasodilator, is a widely used medication for the management of hypertension and heart failure, especially for patients who cannot tolerate the use of ACEIs or ARBs." | 5.12 | Hydralazine-Induced ANCA Associated Vasculitis (AAV) Presenting with Pulmonary-Renal Syndrome (PRS): A Case Report with Literature Review. ( Al-Sadawi, M; Battisha, A; Doughem, K; Konduru, L; Madoukh, B; Shaikh, S; Sheikh, O, 2021) |
"Hydralazine is a common vasodilator which has been used for the treatment of hypertension and heart failure." | 3.96 | Hydralazine-induced antineutrophil cytoplasmic antibody-associated vasculitis with pulmonary-renal syndrome: a case report. ( Al-Abdouh, A; Bekele, A; Garcia, P; Seid, H; Siyal, AM, 2020) |
"We report a rare case of Hydralazine-induced ANCA associated glomerulonephritis with alveolar hemorrhage in the setting of acute Clostridium Difficile Infection." | 3.83 | Hydralazine-Induced ANCA Vasculitis in the Setting of Acute Clostridium Difficile Infection. ( Cucu, DF; El Meligy, A; Rasla, S, 2016) |
"Hydralazine-induced lupus was first described in 1953." | 1.48 | Hydralazine-associated antineutrophil cytoplasmic antibody vasculitis with pulmonary-renal syndrome. ( Aeddula, NR; Ansari, A; Juran, PJ; Pathireddy, S, 2018) |
"Hydralazine is a commonly used drug for treatment of hypertension and is known to cause drug-induced lupus erythematosus." | 1.38 | Hydralazine-induced ANCA vasculitis with pulmonary renal syndrome: a rare clinical presentation. ( Kaw, D; Malhotra, D; Marina, VP, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (40.00) | 18.7374 |
1990's | 1 (6.67) | 18.2507 |
2000's | 2 (13.33) | 29.6817 |
2010's | 4 (26.67) | 24.3611 |
2020's | 2 (13.33) | 2.80 |
Authors | Studies |
---|---|
Al-Abdouh, A | 1 |
Siyal, AM | 1 |
Seid, H | 1 |
Bekele, A | 1 |
Garcia, P | 1 |
Doughem, K | 1 |
Battisha, A | 1 |
Sheikh, O | 1 |
Konduru, L | 1 |
Madoukh, B | 1 |
Al-Sadawi, M | 1 |
Shaikh, S | 1 |
Aeddula, NR | 1 |
Pathireddy, S | 1 |
Ansari, A | 1 |
Juran, PJ | 1 |
Rasla, S | 1 |
El Meligy, A | 1 |
Cucu, DF | 1 |
Kalra, A | 1 |
Yokogawa, N | 1 |
Raja, H | 1 |
Palaniswamy, C | 1 |
Desai, P | 1 |
Zanotti-Cavazzoni, SL | 1 |
Rajaram, SS | 1 |
Marina, VP | 1 |
Malhotra, D | 1 |
Kaw, D | 1 |
BENDERSKY, G | 1 |
RAMIREZ, C | 1 |
Martin-Cora, FJ | 1 |
Fornal, CA | 2 |
Jacobs, BL | 2 |
Ahlgren, J | 1 |
Porter, K | 1 |
Hayward, LF | 1 |
Moreau, P | 1 |
Drolet, G | 1 |
Yamaguchi, N | 1 |
de Champlain, J | 1 |
Drózdz, M | 1 |
Kucharz, E | 1 |
Wieczorek, M | 1 |
Powers, JC | 1 |
Shaftan, GW | 1 |
Herbsman, H | 1 |
Mesfin, GM | 1 |
Shawaryn, GG | 1 |
Higgins, MJ | 1 |
Morilak, DA | 1 |
Bozović, L | 1 |
Castenfors, J | 1 |
1 review available for hydralazine and Hemorrhage
Article | Year |
---|---|
Hydralazine-Induced ANCA Associated Vasculitis (AAV) Presenting with Pulmonary-Renal Syndrome (PRS): A Case Report with Literature Review.
Topics: Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Female; Glomerulonephritis; Heart | 2021 |
14 other studies available for hydralazine and Hemorrhage
Article | Year |
---|---|
Hydralazine-induced antineutrophil cytoplasmic antibody-associated vasculitis with pulmonary-renal syndrome: a case report.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Female; Glomerulonephritis; Hemorrhage; | 2020 |
Hydralazine-associated antineutrophil cytoplasmic antibody vasculitis with pulmonary-renal syndrome.
Topics: Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Biopsy; Blood Protein Electrophore | 2018 |
Hydralazine-Induced ANCA Vasculitis in the Setting of Acute Clostridium Difficile Infection.
Topics: Adrenal Cortex Hormones; Aged; Antibodies, Antineutrophil Cytoplasmic; Antihypertensive Agents; Clos | 2016 |
Hydralazine-induced pulmonary-renal syndrome: a case report.
Topics: Aged; Female; Glomerulonephritis; Glucocorticoids; Hemorrhage; Humans; Hydralazine; Immunosuppressiv | 2012 |
Hydralazine-induced ANCA vasculitis with pulmonary renal syndrome: a rare clinical presentation.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antihypertensive Agents; Glomerulonephri | 2012 |
Hydralazine poisoning. Review of the literature and autopsy study of person with massive intestinal bleeding.
Topics: Autopsy; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Hydralazine | 1960 |
Single-unit responses of serotonergic medullary raphe neurons to cardiovascular challenges in freely moving cats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Action Potentials; Animals; Behavior, Animal; Cardiovascular | 2005 |
Hemodynamic responses and c-Fos changes associated with hypotensive hemorrhage: standardizing a protocol for severe hemorrhage in conscious rats.
Topics: Animals; Blood Pressure; Blood Volume; Brain; Consciousness; Heart Rate; Hemorrhage; Hydralazine; Hy | 2007 |
Role of presynaptic beta 2-adrenergic facilitation in the development and maintenance of DOCA-salt hypertension.
Topics: Adrenalectomy; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Catec | 1993 |
Morphological changes observed after stimulation or inhibition of adrenic system in rats chronically treated with hydrazinophtalazines.
Topics: Animals; Catecholamines; Epinephrine; Heart; Heart Diseases; Hemorrhage; Hydralazine; Inflammation; | 1979 |
Evaluation of various hypotensive agents in the control of experimental hemorrhage.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Chlorpromazine; Diazoxide; Dogs; Drug Evaluation, | 1975 |
Cardiovascular alterations in dogs treated with hydralazine.
Topics: Animals; Blood Chemical Analysis; Body Weight; Dogs; Heart; Heart Rate; Hemorrhage; Hydralazine; Mal | 1987 |
Effects of physiological manipulations on locus coeruleus neuronal activity in freely moving cats. II. Cardiovascular challenge.
Topics: Action Potentials; Animals; Blood Volume; Cardiovascular Physiological Phenomena; Cardiovascular Sys | 1987 |
Effect of hydralazine and pentolinium on renin release caused by bleeding in rats.
Topics: Animals; Blood Pressure; Female; Hematocrit; Hemorrhage; Hydralazine; Kidney; Pentolinium Tartrate; | 1967 |